Christof Geldmacher

Christof Geldmacher is a senior scientist at the Department for Infectious Diseases & Tropical Medicine, University of Munich (LMU) and a member of the German Center for Infection Research (DZIF). Dr. Geldmacher performed his PhD thesis practical work at the Mbeya Medical Research Center and thereafter joined Richard Koup`s laboratory as a Post-Doctorate at the Vaccine Research Center of the NIH in Bethesda to continue research on pathogen-specific T cells. He is the Principle Investigator of the “HIV and HPV interaction” study that dissects the influence of HIV infection and treatment with antiretroviral therapy on Human Papillomavirus infection, disease and immunity. The immunology and pathogenesis of HIV and opportunistic infections (Mycobacterium tuberculosis (MTB), Human Papilloma Viruses (HPV)) are among his primary area of research. To date, he has more than 20 peer-reviewed publications in the field of human immunology; these include a number of studies published in high impact journals, including Lancet Infect Dis, J Exp Med and Blood. Furthermore, Dr. Geldmacher is involved in the development of novel immunodiagnostic tools for active Tuberculosis, immunogenicity testing of new HIV vaccine candidates and aims to help improve vaccine design for variable pathogens. For many years he has been supporting research in immunology and infectious diseases locally in Africa, but he currently also leads an Infectious disease Immunology laboratory in Munich.


Responsive Free Joomla template by L.THEMESEO